Ceapro Announces Granting of Stock Options
EDMONTON, ALBERTA -- (MARKET WIRE) -- 01/07/08 -- Ceapro Inc. (TSX VENTURE: CZO) today announced the granting of 345,000 stock options, subject to approval by the TSX-Venture Exchange. The exercise price is $0.25.Two Officers were each awarded 150,000 options with the balance distributed to Ceapro employees.
The options were awarded in accordance with the Stock Option Plan approved by Shareholders on June 1, 2005 and the TSX-Venture Exchange on July 6, 2005.
Ceapro's President and CEO, Dr. Mark Redmond, explained, "Stock options are critical in retaining key employees, providing long-term compensation and incentive to increase the Company's value. The current awards recognize significant contributions especially in new product development, production expansion, and new market entry. In 2007, Ceapro penetrated the important diabetes screening market with CeaProve®, and began sales of certified organic extracts to the personal care/cosmeceutical market."
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Our primary business activities relate to the development and commercialization of organic products for medical, cosmetic and animal health industries using proprietary technology and natural, renewable resources. We will be applying our technology to become an active participant in the bio-energy sector. We have also introduced health and wellness services employing our CeaProve® diagnostic technology. To learn more about Ceapro, visit www.ceapro.com .
The TSX has neither approved nor disapproved of the information contained herein -
This release may contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. All forward-looking statements are expressly qualified in their entirety by this cautionary statement
Contacts: Ceapro Inc. Dr. Mark Redmond President and CEO (Edmonton): 780-421-4555 firstname.lastname@example.org Sun International Communications Nicole Blanchard, B.Sc., B.Comm. Managing Partner (Montreal): 450-973-6600 email@example.com
Released January 7, 2008